0%
0%
0%
0%
0%
−2.63USD
−40.37MUSD
About Celcuity Inc.
Sector
Industry
CEO
Brian F. Sullivan
Website
Headquarters
Minneapolis
Employees
45
Founded
2012
ISIN
US15102K1007
Celcuity, Inc. is cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. Its proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.
Celcuity's Breast Cancer Drug Trial Shows Encouraging ResultsLook at that big fat volume bar off the back of the successful trial news. The company's stock price has been growing steadily up some 164% over the last 12 months, and this news could help propel it back up to previous highs so there might be a bit in it. Worth a watch.
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
